Search

Your search keyword '"Rytter, Dorte"' showing total 240 results
Start Over Author "Rytter, Dorte"
240 results on '"Rytter, Dorte"'

9. Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis

Author

Krogsgaard, Lene Wulff, Petersen, Irene, Plana-Ripoll, Oleguer, Bech, Bodil Hammer, Lützen, Tina Hovgaard, Thomsen, Reimar Wernich, and Rytter, Dorte

Subjects
Chronic fatigue syndrome -- Risk factors -- Statistics, Papillomavirus infections -- Control -- Care and treatment -- Statistics, Biological sciences
Abstract

Background Public trust in the human papilloma virus (HPV) vaccination programme has been challenged by reports of potential severe adverse effects. The reported adverse symptoms were heterogeneous and overlapping with those characterised as chronic fatigue syndrome (CFS) and have been described as CFS-like symptoms. Evidence suggests that CFS is often precipitated by an infection. The aim of the study was to examine if an infection in temporal proximity to HPV vaccination is a risk factor for suspected adverse effects following HPV vaccination. Methods and findings The study was a nationwide register-based cohort study and case-crossover analysis. The study population consisted of all HPV vaccinated females living in Denmark, born between 1974 and 2006, and vaccinated between January 1, 2006 and December 31, 2017. The exposure was any infection in the period ± 1 month around time of first HPV vaccination and was defined as (1) hospital-treated infection; (2) redemption of anti-infective medication; or (3) having a rapid streptococcal test done at the general practitioner. The outcome was referral to a specialised hospital setting (5 national HPV centres opened June 1, 2015) due to suspected adverse effects following HPV vaccination. Multivariable logistic regression was used to estimate the association between infection and later HPV centre referral. The participants were 600,400 HPV-vaccinated females aged 11 to 44 years. Of these, 48,361 (9.7%) females had a hospital-treated infection, redeemed anti-infective medication, or had a rapid streptococcal test ± 1 month around time of first HPV vaccination. A total of 1,755 (0.3%) females were referred to an HPV centre. Having a hospital-treated infection in temporal proximity to vaccination was associated with significantly elevated risk of later referral to an HPV centre (odds ratio (OR) 2.75, 95% confidence interval (CI) 1.72 to 4.40; P < 0.001). Increased risk was also observed among females who redeemed anti-infective medication (OR 1.56, 95% CI 1.33 to 1.83; P < 0.001) or had a rapid streptococcal test (OR 1.45, 95% CI 1.10 to 1.93; P = 0.010). Results from a case-crossover analysis, which was performed to adjust for potential unmeasured confounding, supported the findings. A key limitation of the study is that the HPV centres did not open until June 1, 2015, which may have led to an underestimation of the risk of suspected adverse effects, but stratified analyses by year of vaccination yielded similar results. Conclusions Treated infection in temporal proximity to HPV vaccination is associated with increased risk for later referral with suspected adverse vaccine effects. Thus, the infection could potentially be a trigger of the CFS-like symptoms in a subset of the referred females. To our knowledge, the study is the first to investigate the role of infection in the development of suspected adverse effects after HPV vaccination and replication of these findings are needed in other studies., Author(s): Lene Wulff Krogsgaard 1,*, Irene Petersen 2,3, Oleguer Plana-Ripoll 4, Bodil Hammer Bech 1, Tina Hovgaard Lützen 1, Reimar Wernich Thomsen 2, Dorte Rytter 1 Introduction Human papilloma virus [...]

Published
2021
Full Text
View/download PDF

13. Healthcare Use in the Five Years Before a First Infertility Diagnosis: A Danish Register-Based Case–Control Study in the CROSS-TRACKS Cohort

Author

Ebdrup,Ninna Hinchely, Riis,Anders Hammerich, Ramlau-Hansen,Cecilia Høst, Bay,Bjørn, Lyngsø,Julie, Rytter,Dorte, Jørgensen,Marianne Johansson, Knudsen,Ulla Breth, Ebdrup,Ninna Hinchely, Riis,Anders Hammerich, Ramlau-Hansen,Cecilia Høst, Bay,Bjørn, Lyngsø,Julie, Rytter,Dorte, Jørgensen,Marianne Johansson, and Knudsen,Ulla Breth

Abstract

Ninna Hinchely Ebdrup,1– 3 Anders Hammerich Riis,4,5 Cecilia Høst Ramlau-Hansen,2 Bjørn Bay,1,6 Julie Lyngsø,7 Dorte Rytter,2 Marianne Johansson Jørgensen,4 Ulla Breth Knudsen1,3 1Department of Obstetrics and Gynecology, Fertility Clinic, Horsens Regional Hospital, Horsens, Denmark; 2Department of Public Health, Aarhus University, Aarhus, Denmark; 3Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 4Department of Research, Regional Hospital Horsens, Horsens, Denmark; 5Enversion A/S, Aarhus, Denmark; 6Maigaard Fertility Clinic, Aarhus, Denmark; 7Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, DenmarkCorrespondence: Ninna Hinchely Ebdrup, Department of Obstetrics and Gynecology, Fertility Clinic, Horsens Regional Hospital, Sundvej 30, Horsens, 8700, Denmark, Tel +45 28 47 21 11, Email ninebd@clin.au.dkPurpose: Infertility may affect somatic and mental health later in life. Nevertheless, health status before diagnosed infertility is sparsely studied in women. We aimed to describe healthcare use in primary and secondary care before a first infertility diagnosis and compare use between cases and controls.Materials and Methods: The case–control study was based on register data and used incidence density sampling. From the CROSS-TRACKS Cohort, we included women residing in the Horsens area in Denmark in 2012– 2018 (n = 54,175). Eligible women were aged 18– 40 years, nulliparous, and living in heterosexual relationships. Cases were women with a first infertility diagnosis in the Danish National Patient Registry (index date). Five controls were matched on age, birth year, and calendar time. Through linkage to Danish national health registries, we identified general practitioner (GP) attendance, paraclinical examinations, hospital contacts, diagnoses, and redeemed prescriptions. Healthcare use from one year to five years before index date was compared with conditional logistic regression.Results: We identified 711 cas

Published
2022

17. General Practitioner Attendance in Proximity to HPV Vaccination: A Nationwide, Register-Based, Matched Case–Control Study

Author

Lützen, Tina Hovgaard, Rask, Charlotte Ulrikka, Plana-Ripoll, Oleguer, Bech, Bodil Hammer, Krogsgaard, Lene Wulff, Rolving, Nanna, and Rytter, Dorte

Subjects
HPV vaccination, Adverse effects, general practice attendance, adverse effects, case–control, General practice attendance, Case–control, Original Research
Abstract

Aim: This study aimed to describe and compare general practitioner (GP) attendance patterns in the years surrounding HPV-vaccination among cases suspected to experience adverse events and their matched controls in order to determine if a potential larger change in GP attendance among cases was observed in temporal relation to vaccination. Methods: Register-based, matched case–control study. Cases were defined as women referred to specialized hospital settings (HPV-centers) for suspected adverse event between June 1st 2015 and December 31st 2015 (n=1458). Information on referral was obtained from the HPV-centers directly. Each case was matched with five controls on age at vaccination, region, time of first vaccine registration and total number of doses, resulting in a total study population of 8670 girls and women. Negative binomial regression analyses were used (i) to estimate mean yearly GP contacts among cases and controls, and (ii) to further investigate the relative difference in change in GP attendance following vaccination between cases and controls. Results: Overall, cases displayed higher GP attendance than controls from five years before vaccination up until five years after. Compared to controls, cases increased their GP attendance more in the years following HPV vaccination, corresponding to a 40% increase in the incidence rate ratios (IRR) from before to after vaccination (ratio-IRR = 1.40 [1.36; 1.44]). The change occurred in close proximity to vaccination, and the pattern was the same independently of the year of vaccination. However, for the later vaccination years cases displayed an additional increase in their GP attendance around time of extensive media attention. Conclusion: Girls and women being referred for suspected adverse events after HPVvaccination changed their GP attendance pattern in close proximity to their first HPVvaccination and not solely in temporal linkage to the onset of public debate.

Published
2020

19. Polygenic Risk Score Prediction for Endometriosis

Author

Kloeve-Mogensen, Kirstine, primary, Rohde, Palle Duun, additional, Twisttmann, Simone, additional, Nygaard, Marianne, additional, Koldby, Kristina Magaard, additional, Steffensen, Rudi, additional, Dahl, Christian Møller, additional, Rytter, Dorte, additional, Overgaard, Michael Toft, additional, Forman, Axel, additional, Christiansen, Lene, additional, and Nyegaard, Mette, additional

Published
2021
Full Text
View/download PDF

20. Pre-adolescents with multiple health complaints redeem more prescriptions: A follow-up study in the Danish National Birth Cohort.

Author

Bernstorff, Martin, Rask, Charlotte Ulrikka, Rytter, Dorte, Hansen, Stefan Nygaard, and Bech, Bodil Hammer

Subjects
REPORTING of diseases, WELL-being, PSYCHIATRIC drugs, CONFIDENCE intervals, HEALTH status indicators, REGRESSION analysis, DISEASES, PUBLIC health, ADOLESCENT health, DRUGS, DESCRIPTIVE statistics, HEALTH behavior, SOCIODEMOGRAPHIC factors, LONGITUDINAL method, EDUCATIONAL attainment
Abstract

Aims: This study aimed to examine the association between multiple health complaints (MHC) in pre-adolescence and prescription redemption in adolescence. Methods: This was a nationwide population-based study based on the Danish National Birth Cohort for an average of 6.9 years (2010–2018). A total of 96,382 children were invited at the age of 11. A modified version of the Health Behaviour in School Children Symptom Checklist was dichotomised into the World Health Organization's definition of MHC (⩾2 complaints, each with a frequency of at least weekly, yes/no). The number of prescriptions was retrieved from Danish registries. Negative binomial regression estimated incidence rate ratios (IRRs) comparing children with MHC to children without. Prescription redemption was further stratified by psychiatric/somatic medication and into subtypes of prescriptions. Results: A total of 47,365 (49.1%) children participated (M age=11.2 years, 52% girls). MHC were reported by 10.3%. The unadjusted IRR (MHC vs. no MHC) of all types of redemptions was 1.57 (95% confidence interval (CI) 1.49–1.64). Results were robust to adjustment for socio-demographic variables and somatic/psychiatric morbidity at baseline (IRR=1.47; 95% CI 1.40–1.54). Associations were especially strong for psychiatric medication (adjusted IRR=3.88; 95% CI 3.43–4.40) and were modified by neither sex nor maternal education. Conclusions: MHC in pre-adolescents predict prescription redemption. This implies that changes in MHC might be indicative of changes in public health. This requires further study, as the cause of a change in reporting of symptoms might also cause a change in treatment response. The latter determines whether prescriptions are treating ill-being or needlessly medicalising subjective symptoms. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

26. sj-docx-1-sjp-10.1177_14034948211036619 – Supplemental material for Pre-adolescents with multiple health complaints redeem more prescriptions: A follow-up study in the Danish National Birth Cohort

Author

Bernstorff, Martin, Rask, Charlotte Ulrikka, Rytter, Dorte, Hansen, Stefan Nygaard, and Bech, Bodil Hammer

Subjects
111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences
Abstract

Supplemental material, sj-docx-1-sjp-10.1177_14034948211036619 for Pre-adolescents with multiple health complaints redeem more prescriptions: A follow-up study in the Danish National Birth Cohort by Martin Bernstorff, Charlotte Ulrikka Rask, Dorte Rytter, Stefan Nygaard Hansen and Bodil Hammer Bech in Scandinavian Journal of Public Health

Published
2021
Full Text
View/download PDF

27. Human papillomavirus vaccination and all-cause morbidity in adolescent girls:a cohort study of absence from school due to illness

Author

Hviid, Anders, Thorsen, Nicklas M., Thomsen, Louise N., Møller, Frederik T., Wiwe, Andreas, Frisch, Morten, Valentiner-Branth, Palle, Rytter, Dorte, Mølbak, Kåre, Hviid, Anders, Thorsen, Nicklas M., Thomsen, Louise N., Møller, Frederik T., Wiwe, Andreas, Frisch, Morten, Valentiner-Branth, Palle, Rytter, Dorte, and Mølbak, Kåre

Abstract

BACKGROUND: A growing body of evidence supports the safety of the human papillomavirus (HPV) vaccines. However, concerns about autonomic dysfunction syndromes and non-specific symptoms continue to linger. These conditions are not easily captured by traditional diagnostic classification schemes and call for innovative approaches to the study of vaccine safety which take more general measures of all-cause morbidity into account. METHODS: Taking advantage of the unique Danish registers, including regional registration of absence from school, we conducted a cohort study of 14 068 adolescent Danish girls attending 5th through 9th grade in public schools in the municipality of Copenhagen during 1 August 2013-23 January 2018. We obtained time-varying HPV vaccination status and demographic information from nationwide registers. Using Poisson regression with random effects, we estimated rate ratios (RRs) of absence due to illness, comparing HPV-vaccinated girls with unvaccinated girls with adjustment for grade, season, calendar period, demographic factors and random effects at the individual, class and school levels. RESULTS: Our study included 6 206 188 school days with 213 221 days of absence from school due to illness (absence rate, 3.4%). Comparing absence rates due to illness in HPV-vaccinated and unvaccinated girls yielded an adjusted RR of 1.00 (95% confidence interval [CI], 0.98-1.03). CONCLUSIONS: Our study provides an important and novel contribution to HPV vaccine safety. Using absence from school records, we were able to address important safety concerns without relying on medical diagnoses. We conclude that HPV vaccination does not increase the risk of morbidity in any manner that manifests as absence from school due to illness.

Published
2021

31. General Practitioner Attendance in Proximity to HPV Vaccination: A Nationwide, Register-Based, Matched Case–Control Study

Author

Hovgaard Lützen,Tina, Rask,Charlotte Ulrikka, Plana-Ripoll,Oleguer, Bech,Bodil Hammer, Krogsgaard,Lene Wulff, Rolving,Nanna, and Rytter,Dorte

Subjects
Clinical Epidemiology
Abstract

Tina Hovgaard Lützen,1 Charlotte Ulrikka Rask,2,3 Oleguer Plana-Ripoll,4 Bodil Hammer Bech,1 Lene Wulff Krogsgaard,1 Nanna Rolving,5,6 Dorte Rytter1 1Research Unit for Epidemiology, Department of Public Health, Aarhus University, Aarhus C 8000, Denmark; 2Research Unit, Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus N 8200, Denmark; 3Department of Clinical Medicine, Aarhus University, Aarhus N 8200, Denmark; 4National Centre for Register-Based Research, Department of Economics and Business Economics, Aarhus University, Aarhus V 8210, Denmark; 5University Clinic of Innovative Patient Pathways, Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg 8600, Denmark; 6DEFACTUM, Corporate Quality, Central Denmark Region, Aarhus N 8200, DenmarkCorrespondence: Tina Hovgaard Lützen Research Unit for Epidemiology, Department of Public HealthAarhus University, Bartholins Allé 2, Aarhus C 8000, DenmarkTel +45 22410722Email tina.lutzen@ph.au.dkAim: This study aimed to describe and compare general practitioner (GP) attendance patterns in the years surrounding HPV-vaccination among cases suspected to experience adverse events and their matched controls in order to determine if a potential larger change in GP attendance among cases was observed in temporal relation to vaccination.Methods: Register-based, matched case–control study. Cases were defined as women referred to specialized hospital settings (HPV-centers) for suspected adverse event between June 1st 2015 and December 31st 2015 (n=1458). Information on referral was obtained from the HPV-centers directly. Each case was matched with five controls on age at vaccination, region, time of first vaccine registration and total number of doses, resulting in a total study population of 8670 girls and women. Negative binomial regression analyses were used (i) to estimate mean yearly GP contacts among cases and controls, and (ii) to further investigate the relative difference in change in GP attendance following vaccination between cases and controls.Results: Overall, cases displayed higher GP attendance than controls from five years before vaccination up until five years after. Compared to controls, cases increased their GP attendance more in the years following HPV vaccination, corresponding to a 40% increase in the incidence rate ratios (IRR) from before to after vaccination (ratio-IRR = 1.40 [1.36; 1.44]). The change occurred in close proximity to vaccination, and the pattern was the same independently of the year of vaccination. However, for the later vaccination years cases displayed an additional increase in their GP attendance around time of extensive media attention.Conclusion: Girls and women being referred for suspected adverse events after HPV-vaccination changed their GP attendance pattern in close proximity to their first HPV-vaccination and not solely in temporal linkage to the onset of public debate.Keywords: HPV vaccination, general practice attendance, adverse effects, case–control

Published
2020

32. Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? – A Danish nationwide matched case-control study

Author

Krogsgaard, Lene Wulff, Helmuth, Ida Glode, Bech, Bodil Hammer, Plana-Ripoll, Oleguer, Lützen, Tina Hovgaard, Vestergaard, Hanne Thang, Bjerre, Karsten Dalsgaard, Thomsen, Reimar Wernich, Mølbak, Kåre, Rytter, Dorte, Krogsgaard, Lene Wulff, Helmuth, Ida Glode, Bech, Bodil Hammer, Plana-Ripoll, Oleguer, Lützen, Tina Hovgaard, Vestergaard, Hanne Thang, Bjerre, Karsten Dalsgaard, Thomsen, Reimar Wernich, Mølbak, Kåre, and Rytter, Dorte

Abstract

Background: In Denmark, the acceptance of the HPV vaccination program has been threatened by reports of suspected adverse events. Epstein Barr Virus (EBV) infection is associated with symptoms of long-lasting tiredness and may be misinterpreted as HPV vaccine adverse events. The main aim of this study was to examine if EBV infection around time of HPV vaccination was a risk factor for later suspected vaccine adverse events. Methods: The study was a nationwide register-based matched case-control study. Cases were females vaccinated against HPV in the period 2011 throughout 2017 with suspected adverse events. For each case, five HPV vaccinated females without suspected adverse events were selected. Information about EBV infection was obtained from the Danish Microbiology Database and assessed for three time periods: (1) before first HPV vaccination, (2) around time of HPV vaccination, and (3) any time during the study period 2010–2017. Multiple logistic regression was used to estimate the association between EBV and suspected adverse events. Results: We identified 1217 cases, matched to 6085 controls. A higher proportion of cases (38; 3.1%) than controls (31; 0.5%) were tested for EBV around time of HPV vaccination and cases had elevated odds for testing both EBV positive (OR 4.52, 95% CI 2.68–7.63) and EBV negative (OR 20.99, 95% CI 5.81–75.79). Only five females were classified with acute/recent EVB infection in this period. Conclusion: Misinterpretation of EBV infection late symptoms is not a leading explanation for Danish females experiencing suspected adverse events after HPV vaccination. Although EBV cannot be excluded as an explanatory factor for a very small proportion of suspected adverse events, the findings are more likely explained by protopathic bias, i.e. the fact that a larger proportion of females suspecting adverse events are tested for EBV.

Published
2020

38. Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? – A Danish nationwide matched case-control study

Author

Krogsgaard, Lene Wulff, primary, Helmuth, Ida Glode, additional, Bech, Bodil Hammer, additional, Plana-Ripoll, Oleguer, additional, Lützen, Tina Hovgaard, additional, Vestergaard, Hanne Thang, additional, Bjerre, Karsten Dalsgaard, additional, Thomsen, Reimar Wernich, additional, Mølbak, Kåre, additional, and Rytter, Dorte, additional

Published
2020
Full Text
View/download PDF

40. Attendance of routine childcare visits in primary care for children of mothers with depression:a nationwide population-based cohort study

Author

Lyngsøe, Bente Kjær, Vestergaard, Claus Høstrup, Rytter, Dorte, Vestergaard, Mogens, Munk-Olsen, Trine, and Bech, Bodil Hammer

Subjects
general practice, SYMPTOMS, MATERNAL DEPRESSION, Denmark, delivery of health care, INFANTS, RISKS, LIFE, maternal, PREGNANCY, HEALTH-CARE, depression, ANXIETY, REGISTER, child care
Abstract

Børn af mødre med depression kommer sjældnere til børneundersøgelser og bliver sjældnere vaccineret end mange andre børn. Dette studie viser, at risikoen for at udeblive fra mindst 50 pct. af alle forebyggende børneundersøgelser var 16 pct. højere for børn af mødre med depression sammenlignet med børn af mødre uden depression. Forskerne fandt, at depression hos moderen øger risikoen for, at barnet ikke deltager i børneundersøgelser og vaccinationer hos den praktiserende læge. Denne sammenhæng ses i flere år, selv når moderen ikke længere kategoriseres som deprimeret. Konsultationer ifm. børne¬undersøgelsen giver lægen mulighed for at identificere psykisk, fysisk eller social mistrivsel, og udeblivelse fra børneundersøgelser eller vaccinationsprogram giver derfor en høj risiko for negative helbreds¬mæssige følger. Resultaterne i dette studie tyder på, at mødet med familier, der kæmper ─ eller tidligere har kæmpet ─ med depression kræver særlig opmærksomhed, hvis velfærden skal nå alle. BACKGROUND: Depression is a common and potentially debilitating illness worldwide. Attendance to routine childcare appointments is a key point of interest in the effort to improve the health and care for families facing depression.AIM: To evaluate the association between maternal depression and offspring non-attendance to the Danish childcare and vaccination programme (CCP) for children from 0-5 years of age. The CCP consists of seven separate visits and several vaccinations. To investigate if exposure to recent and previous depression may affect attendance differently.DESIGN AND SETTING: Population-based cohort study using Danish nationwide registers.METHOD: Participants were all live-born children (n = 853 315) in Denmark in the period from 1 January 2000 until 31 August 2013, and their mothers. The outcome of interest was non-attendance of each one of the seven scheduled childcare visits and two vaccination entities in the CCP. Exposure was maternal (both previous and recent) depression. All information was obtained from Danish national registries.RESULTS: The risk of not attending CCP was higher for children of mothers with depression. For children of mothers with previous depression, the relative risk (RR) was 1.01 (95% confidence interval [CI] = 0.98 to 1.03) at the 5-week childcare visit, and 1.12 (95% CI = 1.09 to 1.14) at the 5-year childcare visit. For children of mothers with recent depression, the RR was 1.07 (95% CI = 1.03 to 1.13) at the 5-week visit, and 1.15 (95% CI = 1.13 to 1.17) at the 5-year visit. Furthermore, the risk of missing at least four of the seven childcare visits was higher for children of females with maternal depression (RR = 1.16, 95% CI = 1.13 to 1.19).CONCLUSION: Maternal depression seems to compromise CCP attendance. These findings suggest a need for careful clinical attention to these vulnerable families, even years after a diagnosis of depression.

Published
2018

45. Maternal depression and non-specific health complaints in the offspring: a cross-sectional study in Danish primary care.

Author

Lyngsøe, Bente Kjær, Rytter, Dorte, Munk-Olsen, Trine, Vestergaard, Claus Høstrup, Christensen, Kaj Sparle, and Bech, Bodil Hammer

Subjects
MOTHER-child relationship, RATIO & proportion, PRIMARY care, CROSS-sectional method, MENTAL depression, MOTHERS, PRIMARY health care, QUESTIONNAIRES
Abstract

Background: Maternal depression has been linked to adverse outcomes in the offspring. Existing literature is mainly based on parental reports, which can be an unreliable source when the parent has depression.Aim: To explore if maternal depression was associated with daily health complaints and low self-assessed health (SAH) in the offspring.Design and Setting: Participants were 45 727 children from the Danish National Birth Cohort recruited between 1996 and 2002. At 11-year follow-up, mothers and their children were invited to complete a questionnaire. Maternal depression was categorised into: no depression, first-time treatment, continued treatment, post-treatment, and relapse.Method: Binomial regression was used to estimate the adjusted prevalence proportion ratio (aPPR) of frequent health complaints and low SAH in children of mothers with depression compared to children of mothers without depression.Results: The prevalence of any daily health complaint was 11.4%, daily somatic complaints 4.1%, daily mental complaints 8.9%, both daily mental and somatic complaints 1.5%, and low SAH 5.3%. Children of mothers with depression (any category) were more likely to report a daily health complaint: first-time treatment aPPR 1.35 (95% confidence interval [CI] = 0.96 to 1.85), continued treatment aPPR 1.59 (95% CI = 1.37 to 1.85), post-treatment aPPR 1.30 (95% CI = 1.20 to 1.41), and relapse aPPR 1.56 (95% CI = 1.35 to 1.79). Children of mothers with depression were also more likely to report low SAH: first-time treatment aPPR 1.58 (95% CI = 0.99 to 2.54), continued treatment aPPR 1.86 (95% CI = 1.51 to 2.28), post-treatment aPPR 1.34 (95% CI = 1.19 to 1.50), and relapse aPPR 1.56 (95% CI = 1.26 to 1.93). Girls had a higher prevalence of mental and somatic health complaints and more often reported low SAH compared to boys.Conclusion: Treatment of maternal depression was associated with higher prevalence of daily health complaints and low SAH in the offspring at age 11 years. The association was strongest for children of mothers with continued depression or relapse. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results